1	Molecular	molecular	_	_	_	_	_	_	_
2	basis	basis	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	multiple	multiple	_	_	_	_	_	_	_
6	lymphokine	lymphokine	_	_	_	_	_	_	_
7	deficiency	deficiency	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	patient	patient	_	_	_	_	_	_	_
11	with	with	_	_	_	_	_	_	_
12	severe	severe	_	_	_	_	_	_	_
13	combined	combined	_	_	_	_	_	_	_
14	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	previously	previously	_	_	_	_	_	_	_
4	reported	report	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	T	t	_	_	_	_	_	_	_
8	lymphocytes	lymphocyte	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	child	child	_	_	_	_	_	_	_
12	with	with	_	_	_	_	_	_	_
13	severe	severe	_	_	_	_	_	_	_
14	combined	combined	_	_	_	_	_	_	_
15	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
16	are	be	_	_	_	_	_	_	_
17	defective	defective	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	transcription	transcription	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	several	several	_	_	_	_	_	_	_
23	lymphokine	lymphokine	_	_	_	_	_	_	_
24	genes	gene	_	_	_	_	_	_	_
25	that	that	_	_	_	_	_	_	_
26	include	include	_	_	_	_	_	_	_
27	IL2	il2	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	IL3	IL3	_	_	_	_	_	_	_
30	,	,	_	_	_	_	_	_	_
31	IL4	IL4	_	_	_	_	_	_	_
32	,	,	_	_	_	_	_	_	_
33	and	and	_	_	_	_	_	_	_
34	IL5	IL5	_	_	_	_	_	_	_
35	,	,	_	_	_	_	_	_	_
36	which	which	_	_	_	_	_	_	_
37	encode	encode	_	_	_	_	_	_	_
38	interleukins	interleukin	_	_	_	_	_	_	_
39	2	2	_	_	_	_	_	_	_
40	,	,	_	_	_	_	_	_	_
41	3	3	_	_	_	_	_	_	_
42	,	,	_	_	_	_	_	_	_
43	4	4	_	_	_	_	_	_	_
44	,	,	_	_	_	_	_	_	_
45	and	and	_	_	_	_	_	_	_
46	5	5	_	_	_	_	_	_	_
47	(	(	_	_	_	_	_	_	_
48	IL-2	IL-2	_	_	_	_	_	_	_
49	,	,	_	_	_	_	_	_	_
50	-3	-3	_	_	_	_	_	_	_
51	,	,	_	_	_	_	_	_	_
52	-4	-4	_	_	_	_	_	_	_
53	,	,	_	_	_	_	_	_	_
54	and	and	_	_	_	_	_	_	_
55	-5	-5	_	_	_	_	_	_	_
56	)	)	_	_	_	_	_	_	_
57	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	determine	determine	_	_	_	_	_	_	_
3	whether	whether	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	defect	defect	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	patient	patient	_	_	_	_	_	_	_
9	’s	's	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	lymphocytes	lymphocyte	_	_	_	_	_	_	_
12	involved	involve	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	trans-acting	trans-acting	_	_	_	_	_	_	_
15	factor	factor	_	_	_	_	_	_	_
16	common	common	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	affected	affect	_	_	_	_	_	_	_
20	lymphokine	lymphokine	_	_	_	_	_	_	_
21	genes	gene	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	we	we	_	_	_	_	_	_	_
24	examined	examine	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	ability	ability	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	nuclear	nuclear	_	_	_	_	_	_	_
29	factors	factor	_	_	_	_	_	_	_
30	from	from	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	patient	patient	_	_	_	_	_	_	_
33	’s	's	_	_	_	_	_	_	_
34	T	t	_	_	_	_	_	_	_
35	lymphocytes	lymphocyte	_	_	_	_	_	_	_
36	to	to	_	_	_	_	_	_	_
37	bind	bind	_	_	_	_	_	_	_
38	response	response	_	_	_	_	_	_	_
39	elements	element	_	_	_	_	_	_	_
40	present	present	_	_	_	_	_	_	_
41	in	in	_	_	_	_	_	_	_
42	the	the	_	_	_	_	_	_	_
43	regulatory	regulatory	_	_	_	_	_	_	_
44	region	region	_	_	_	_	_	_	_
45	of	of	_	_	_	_	_	_	_
46	IL2	il2	_	_	_	_	_	_	_
47	.	.	_	_	_	_	_	_	_

1	Nuclear	nuclear	_	_	_	_	_	_	_
2	factor	factor	_	_	_	_	_	_	_
3	NF-kB	NF-kB	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	activation	activation	_	_	_	_	_	_	_
6	protein	protein	_	_	_	_	_	_	_
7	1	1	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	AP-1	ap-1	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	OCT-1	OCT-1	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	NF-IL-2B	NF-IL-2B	_	_	_	_	_	_	_
16	binding	binding	_	_	_	_	_	_	_
17	activity	activity	_	_	_	_	_	_	_
18	were	be	_	_	_	_	_	_	_
19	normal	normal	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	binding	binding	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	nuclear	nuclear	_	_	_	_	_	_	_
9	factor	factor	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	activated	activate	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	NF-AT	NF-AT	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	its	its	_	_	_	_	_	_	_
19	response	response	_	_	_	_	_	_	_
20	element	element	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	IL2	il2	_	_	_	_	_	_	_
24	enhancer	enhancer	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	to	to	_	_	_	_	_	_	_
27	an	an	_	_	_	_	_	_	_
28	NF-AT-like	nf-at-like	_	_	_	_	_	_	_
29	response	response	_	_	_	_	_	_	_
30	element	element	_	_	_	_	_	_	_
31	present	present	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	IL4	il4	_	_	_	_	_	_	_
35	enhancer	enhancer	_	_	_	_	_	_	_
36	was	be	_	_	_	_	_	_	_
37	abnormal	abnormal	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	ascertain	ascertain	_	_	_	_	_	_	_
3	whether	whether	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	abnormal	abnormal	_	_	_	_	_	_	_
6	NF-AT	nf-at	_	_	_	_	_	_	_
7	binding	binding	_	_	_	_	_	_	_
8	activity	activity	_	_	_	_	_	_	_
9	was	be	_	_	_	_	_	_	_
10	related	relate	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	an	an	_	_	_	_	_	_	_
13	impaired	impaired	_	_	_	_	_	_	_
14	function	function	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	we	we	_	_	_	_	_	_	_
17	transfected	transfecte	_	_	_	_	_	_	_
18	patient	patient	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	control	control	_	_	_	_	_	_	_
21	T	t	_	_	_	_	_	_	_
22	lymphocytes	lymphocyte	_	_	_	_	_	_	_
23	with	with	_	_	_	_	_	_	_
24	constructs	construct	_	_	_	_	_	_	_
25	containing	contain	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	reporter	reporter	_	_	_	_	_	_	_
28	gene	gene	_	_	_	_	_	_	_
29	encoding	encode	_	_	_	_	_	_	_
30	chloramphenicol	chloramphenicol	_	_	_	_	_	_	_
31	acetyl	acetyl	_	_	_	_	_	_	_
32	transferase	transferase	_	_	_	_	_	_	_
33	(	(	_	_	_	_	_	_	_
34	CAT	CAT	_	_	_	_	_	_	_
35	)	)	_	_	_	_	_	_	_
36	under	under	_	_	_	_	_	_	_
37	the	the	_	_	_	_	_	_	_
38	control	control	_	_	_	_	_	_	_
39	of	of	_	_	_	_	_	_	_
40	the	the	_	_	_	_	_	_	_
41	entire	entire	_	_	_	_	_	_	_
42	IL2	il2	_	_	_	_	_	_	_
43	regulatory	regulatory	_	_	_	_	_	_	_
44	region	region	_	_	_	_	_	_	_
45	or	or	_	_	_	_	_	_	_
46	of	of	_	_	_	_	_	_	_
47	multimers	multimer	_	_	_	_	_	_	_
48	of	of	_	_	_	_	_	_	_
49	individual	individual	_	_	_	_	_	_	_
50	enhancer	enhancer	_	_	_	_	_	_	_
51	sequences	sequence	_	_	_	_	_	_	_
52	.	.	_	_	_	_	_	_	_

1	CAT	CAT	_	_	_	_	_	_	_
2	expression	expression	_	_	_	_	_	_	_
3	directed	direct	_	_	_	_	_	_	_
4	by	by	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	IL2	il2	_	_	_	_	_	_	_
7	regulatory	regulatory	_	_	_	_	_	_	_
8	region	region	_	_	_	_	_	_	_
9	or	or	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	multimer	multimer	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	NF-AT-binding	nf-at-binding	_	_	_	_	_	_	_
16	site	site	_	_	_	_	_	_	_
17	was	be	_	_	_	_	_	_	_
18	markedly	markedly	_	_	_	_	_	_	_
19	lower	low	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	patient	patient	_	_	_	_	_	_	_
23	relative	relative	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	controls	control	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	CAT	CAT	_	_	_	_	_	_	_
5	gene	gene	_	_	_	_	_	_	_
6	expression	expression	_	_	_	_	_	_	_
7	directed	direct	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	multimer	multimer	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	OCT-1	oct-1	_	_	_	_	_	_	_
14	proximal	proximal	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	OCT-1p)-binding	oct-1p)-binding	_	_	_	_	_	_	_
17	site	site	_	_	_	_	_	_	_
18	was	be	_	_	_	_	_	_	_
19	equivalent	equivalent	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	patient	patient	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	controls	control	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	indicate	indicate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	an	an	_	_	_	_	_	_	_
6	abnormality	abnormality	_	_	_	_	_	_	_
7	of/or	of/or	_	_	_	_	_	_	_
8	influencing	influence	_	_	_	_	_	_	_
9	NF-AT	NF-AT	_	_	_	_	_	_	_
10	may	may	_	_	_	_	_	_	_
11	underlie	underlie	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	multiple	multiple	_	_	_	_	_	_	_
14	lymphokine	lymphokine	_	_	_	_	_	_	_
15	deficiency	deficiency	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	this	this	_	_	_	_	_	_	_
18	patient	patient	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

